Therapy Areas: Hereditary Disorders
7 November 2017 - - US-based pharmaceutical company Novoclem Therapeutics, Inc's lead inhaled antimicrobial drug candidate, BIOC51, has been designated as a "Qualified Infectious Diseas...
7 November 2017 - - US-based enzyme-based products developer Alcresta Therapeutics, Inc. has presented data for the first time from its ASSURE study, the company said.

This long-term clin...
6 November 2017 - - The New England Journal of Medicine (NEJM) has published two articles with results from Boston, Massachusetts-based serious disease therapeutics developer Vertex Pharmaceuticals In...
2 November 2017 - - US-based biopharmaceutical company Pulmatrix, Inc. (NASDAQ: PULM) has appointed James Roach, MD, FACP, FCCP as its new chief medical officer, the company said.

R...
6 October 2017 - Biopharmaceutical company Motif Bio plc (AIM:MTFB) (NASDAQ:MTFB) will present new pre-clinical data for its investigational drug candidate iclaprim at the IDWeek 2017 conference in Sa...
3 October 2017 - - San Diego, California-based developer of therapies for antibiotic-resistant infections using bacteriophage-based technology AmpliPhi Biosciences Corp. (NYSE MKT: APHB) has published...